Loading...
OTC Markets
Totals
Securities
12,306
Dollar Vol
$2.0B
Share Vol
4B
Trades
367,183

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

BIEL
BioElectronics Corp.

Common Stock

0.0002

0.00

0.00%

0.0001 / 0.0002 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 07/11/2025
Delayed (15 Min) Trade Data: 12:00am 07/11/2025

BioElectronics Corp.

4539 Metropolitan Court

Frederick, MD 21704

Principal Executive Offices:

4539 Metropolitan Court

Frederick, MD 21704

Business Description
BioElectronics develops & commercializes electrical stimulation/neuromodulation technology. Its flagship technology is wearable, non-thermal pulsed shortwave therapy (PSWT), which is used to treat and manage a variety of chronic neurological disorders such as chronic pain. The company boasts 4 FDA 510 (k) clearances for its devices, backed by safety & effectiveness data from 5 randomized, controlled clinical trials and numerous other registry trials. These clearances allow for two broad indications in the treatment of pain, for all anatomical sites: 1) postoperative pain (prescription); and 2) musculoskeletal pain (OTC). The Company holds market authorization in the European Union (CE mark) & ...
More
Financial Reporting
Reporting Status
Alternative Reporting Standard
Audited Financials
Unaudited
CIK
0001320869
Fiscal Year End
12/31
Company Officers & Contacts
Kelly A Whelan
CEO

Kelly Whelan has a degree in Business Management from the University of Maryland, University College and earned a certified public accountant's license in 2001. Ms. Whelan has spent many years as an independent consultant providing accounting, marketing and general business services. Prior to this she served as the Controller of Belfort Furniture, a northern Virginia based retailer that had sales of approximately 40 million dollars annually, during her tenure. Ms. Whelan has also held various positions in accounting in the construction industry.

Board of Directors
Richard Staelin, PhD
Chairman, Independent Director

Richard Staelin is the Gregory Mario and Jeremy Mario Professor Emeritusof Business Administration at the Fuqua School of Business, Duke University. He joined Duke in 1982 after teaching at Carnegie-Mellon University for 13 years. He has also been on the faculties of the Australian Graduate School of Management and the University of Chicago. He was Editor of Marketing Science and President of ISMS. He has won best paper awards at Marketing Science, JMR and JM and was awarded the Converse Award and the AMA Best Educators Award. He is an inaugural fellow in ISMS and the AMA and a fellow in INFORMS. He was awarded the best teaching award for the DKU program in 2016.

Sree Naresh Konerum, PhD
Independent Director

Dr. Koneru is Director of Program Management for a contract manufacturing organization that specializes in the design & development of wearable and implantable active electronic medical devices. In his previous role, Sree served as the VP of Product Development for BioElectronics Corporation, where he was responsible for prototype development, physiological testing/clinical evaluation, and regulatory submissions, culminating in several approvals from the US FDA and a CE marking. He also managed the product life cycle from conception to retail launch for domestic and international channel partners. Sree obtained his doctoral degree in Biomedical Engineering ('15) from the State University of New York at Binghamton, NY- USA. He has a background in bringing Neuromodulation (Electroceuticals) medical devices to market, with research expertise in investigating physiological responses (prototype development and clinical research) of pulsed radiofrequency electromagnetic fields. His vision is to be an industry leader in developing transcutaneous, percutaneous, implantable, and electromagnetic neuromodulation technologies, intended to treat chronic diseases.

Kelly A Whelan
CEO

Kelly Whelan has a degree in Business Management from the University of Maryland, University College and earned a certified public accountant's license in 2001. Ms. Whelan has spent many years as an independent consultant providing accounting, marketing and general business services. Prior to this she served as the Controller of Belfort Furniture, a northern Virginia based retailer that had sales of approximately 40 million dollars annually, during her tenure. Ms. Whelan has also held various positions in accounting in the construction industry.

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
CFO Chesapeake LLC

1680 Nickerson Way

Arnold, ME 21012

Profile Data
SIC - Industry Classification
3845 - Electromedical equipment
Incorporation Information
MD, US, 2000
Employees
8 as of 06/17/2024
Shell
No
Products and Services

BioElectronics is an electroceutical company that develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Our innovative pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. The neuromodulation basis of PSWT presents significant opportunities for BioElectronics to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. In February 2017, BioElectronics announced that it received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to plantar fasciitis of the heel, and osteoarthritis of the knee. On July 1, 2019, the Company announced that it has received market clearance from the United States Food and Drug Administration (US FDA) for its RecoveryRx® medical device, for the treatment of postoperative pain. In February 2020, BioElectronics obtained a new 510(k) clearance from the U.S. FDA, granting over-the-counter marketing clearance for the drug-free ActiPatch® medical device, to cover all musculoskeletal pain complaints. This paves the way for new products to treat all medical claims for musculoskeletal pain, including in the back, knee, hips, wrists, elbow, and ankle.

Company Facilities

The Company presently leases 4,100 sq. ft of space. The lease commenced on November 1, 2008, and is currently on a month-to-month lease. The main office consists of seven (7) offices, a conference room and reception area to accommodate staff and complete business activities. A separate area of space is dedicated to product, storage, packaging, machines, tables, and shipping supplies. It is well equipped with desks, computers, furniture, chairs, telephones, printers, copier, fax machine, cabinets and office supplies. The Company owns all furniture and fixtures.

The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.
Limited Information Icon
Pink Limited Information
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.